APLIF
APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF)
$01
About APPILI THERAPEUTICS INC by Appili Therapeutics Inc. (APLIF)
Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.03
52 Week Low
$0.01
Market cap
1.0M
Dividend yield
0.00%
Volume
--
Avg. volume
6,023
P/E ratio
-.32
APPILI THERAPEUTICS INC by Appili Therapeutics Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.03
52 Week Low
$0.01
Market cap
1.0M
Dividend yield
0.00%
Volume
--
Avg. volume
6,023
P/E ratio
-.32